Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Hydrix Limited ( (AU:HYD) ) is now available.
Hydrix Limited, through its subsidiary Hydrix Services, has secured a $2.8 million contract extension with European medical device company Paul Hartmann AG, as part of a multi-stage product development program. This contract reinforces Hydrix’s strategy of global expansion and highlights its commitment to innovation and excellence, with expected revenue recognition by September 2025, signaling a strengthening international market presence.
More about Hydrix Limited
Hydrix Limited is a product innovation company focused on enhancing health, safety, and well-being globally. It operates in three segments: Services, which designs and delivers innovative products; Ventures, investing in high-potential MedTech clients; and Medical, distributing disruptive cardiovascular products.
YTD Price Performance: 10.0%
Average Trading Volume: 245,662
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$3M
See more data about HYD stock on TipRanks’ Stock Analysis page.
